Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriageAdalgisa Pietropolli, Carlo Ticconi, Emma Giuliani et al.|Journal of Obstetrics and Gynaecology|2014Cited by 17
<i>OLR1</i> and <i>Loxin</i> Expression in PBMCs of Women with a History of Unexplained Recurrent Miscarriage: A Pilot StudyValentina Bruno, Francesca Amati, Barbara Rizzacasa et al.|Genetic Testing and Molecular Biomarkers|2017Cited by 8
The impact of Substantial LYMphovascular space invasion on sentinel lymph nodes status and recurrence in Endometrial Cancer patients: SLYM-EC a multicenter retrospective studyAlessandro Buda, Michael D. Mueller, Virginia García-Pineda et al.|European Journal of Surgical Oncology|2024Cited by 7
SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancerJessica Mauro, Alessandro Buda, Michael D. Mueller et al.|European Journal of Surgical Oncology|2025Cited by 5
Long-Term Prognostic Impact Of LVSI In Apparent Early-Stage Endometrioid Endometrial Cancer: The SLYM-EC II Retrospective International Collaborative Study.Alessandro Buda, Michael D. Mueller, Jessica Mauro et al.|International Journal of Gynecological Cancer|2025Cited by 0